COMP and CXCL10: a novel immunogenic cell death-derived gene signature for prognostic prediction in colorectal cancer
6 affiliations
- 1Department of Hematology, Yunnan New Kunhua Hospital, Anning City, Yunnan, China
- 2Department of Gerontology, Yan’an Hospital of Kunming City, Kunming, Yunnan, China
- 3Department of Hematology, Affiliated Qujing Hospital of Kunming Medical University, Qujing, Yunnan, China
- 4Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China
- 5The People’s Hospital of Gaozhou, Gaozhou, Guangdong, China
- 6Department of Colorectal Surgery, Peking University Cancer Hospital Yunnan (Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University), Kunming, Yunnan, China
Abstract
Background: Colorectal cancer (CRC) continues to be a major contributor to cancer-related mortality, with advancements in immunotherapy progress impeded by suboptimal patient responses. Immunogenic cell death (ICD), a distinct process that promotes antitumor immunity, has garnered significant attention in oncological research. However, prognostic models based on ICD for CRC remain insufficiently investigated. This study aimed to analyze ICD-related genes (ICDRGs) in CRC and to develop a prognostic framework that enhances the understanding of disease mechanisms to identify potential prognostic markers.
Methods: Data from TCGA-CRC, GSE17536 , and ICDRGs were integrated to identify differentially expressed genes (DEGs) between tumor and normal tissues. A weighted gene co-expression network analysis (WGCNA) identified modules associated with immunogenic cell death (ICD) using ssGSEA-derived ICD scores. The intersection of DEGs and module genes formed the candidate set. Prognostic determinants and risk factors were identified to develop the risk and prognostic models. Functional enrichment analyses were conducted on risk groups to elucidate CRC-related pathways. Immune infiltration patterns and MSI statuses were assessed in TCGA-CRC. Additionally, drug sensitivity was compared between high- and low-risk groups and between MSI-H and MSI-L/MSS cohorts. Finally, the expression of prognostic genes was validated in CRC and adjacent non-tumor tissues using qRT-PCR.
Results: The overlap between 979 differentially expressed genes (DEGs) and 1,217 modular genes in TCGA-CRC identified 47 candidate genes. From this set, five genes retained in the multivariate Cox regression, GPRASP1, FAT4, MEIS2, COMP, and CXCL10, were incorporated into a risk model that showed moderate predictive accuracy in the GSE17536 validation cohort. A nomogram integrating the risk score with age and T, N, and M stages was subsequently established. An immune infiltration analysis revealed a significant association between risk score and regulatory T cells (Tregs), while CXCL10 exhibited a pronounced positive correlation with multiple immune checkpoints. Drug sensitivity assessments revealed significant disparities in responses to standard chemotherapeutic agents between high- and low-risk groups, as well as between MSI-H and MSI-L/MSS cohorts. Furthermore, a qRT-PCR analysis confirmed significant overexpression of COMP and CXCL10 in CRC tissues.
Conclusions: This study identified COMP and CXCL10 as significantly expressed prognostic genes in colorectal cancer and introduced a novel immune cell death-associated prognostic model. The model exhibited consistent predictive reliability across both training and validation datasets, providing valuable insights for prognosis assessment and therapeutic strategies in CRC.
Related
- A novel CAF-related gene signature for prognostic and immunotherapy response prediction in PDAC based on single-cell RNA-seq and bulk RNA-seq data
- Characterization of the crotonylation landscape in gastric cancer: a machine learning-derived prognostic signature and the oncogenic role of TIMP1
- Construction of a prognostic model and immune landscape analysis for lung adenocarcinoma utilizing a bioinformatics signature derived from acrolein-related genes, and identification of associated subtypes.
- Pseudotime‐Derived Seven‐Gene Prognostic Signature and TYRP1 in Melanoma
- MGP_HNSC32: A H&E Morphology‐Derived 32‐Gene Prognostic Signature in Head and Neck Squamous Cell Carcinoma
BibTeX
@article{tang2026comp,
title = {{COMP and CXCL10: a novel immunogenic cell death-derived gene signature for prognostic prediction in colorectal cancer}},
author = {Ruilong Tang and Yahong Li and Min Liu and Xingyu Tao and Tao Shen and Tao Wu},
journal = {PeerJ},
year = {2026},
month = oct,
doi = {10.7717/peerj.21788},
url = {https://peerj.com/articles/21788},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - COMP and CXCL10: a novel immunogenic cell death-derived gene signature for prognostic prediction in colorectal cancer
AU - Ruilong Tang
AU - Yahong Li
AU - Min Liu
AU - Xingyu Tao
AU - Tao Shen
AU - Tao Wu
PY - 2026
DA - 2026/10/20
JO - PeerJ
DO - 10.7717/peerj.21788
UR - https://peerj.com/articles/21788
AB - Background: Colorectal cancer (CRC) continues to be a major contributor to cancer-related mortality, with advancements in immunotherapy progress impeded by suboptimal patient responses. Immunogenic cell death (ICD), a distinct process that promotes antitumor immunity, has garnered significant attention in oncological research. However, prognostic models based on ICD for CRC remain insufficiently investigated. This study aimed to analyze ICD-related genes (ICDRGs) in CRC and to develop a prognostic framework that enhances the understanding of disease mechanisms to identify potential prognostic markers. Methods: Data from TCGA-CRC, GSE17536 , and ICDRGs were integrated to identify differentially expressed genes (DEGs) between tumor and normal tissues. A weighted gene co-expression network analysis (WGCNA) identified modules associated with immunogenic cell death (ICD) using ssGSEA-derived ICD scores. The intersection of DEGs and module genes formed the candidate set. Prognostic determinants and risk factors were identified to develop the risk and prognostic models. Functional enrichment analyses were conducted on risk groups to elucidate CRC-related pathways. Immune infiltration patterns and MSI statuses were assessed in TCGA-CRC. Additionally, drug sensitivity was compared between high- and low-risk groups and between MSI-H and MSI-L/MSS cohorts. Finally, the expression of prognostic genes was validated in CRC and adjacent non-tumor tissues using qRT-PCR. Results: The overlap between 979 differentially expressed genes (DEGs) and 1,217 modular genes in TCGA-CRC identified 47 candidate genes. From this set, five genes retained in the multivariate Cox regression, GPRASP1, FAT4, MEIS2, COMP, and CXCL10, were incorporated into a risk model that showed moderate predictive accuracy in the GSE17536 validation cohort. A nomogram integrating the risk score with age and T, N, and M stages was subsequently established. An immune infiltration analysis revealed a significant association between risk score and regulatory T cells (Tregs), while CXCL10 exhibited a pronounced positive correlation with multiple immune checkpoints. Drug sensitivity assessments revealed significant disparities in responses to standard chemotherapeutic agents between high- and low-risk groups, as well as between MSI-H and MSI-L/MSS cohorts. Furthermore, a qRT-PCR analysis confirmed significant overexpression of COMP and CXCL10 in CRC tissues. Conclusions: This study identified COMP and CXCL10 as significantly expressed prognostic genes in colorectal cancer and introduced a novel immune cell death-associated prognostic model. The model exhibited consistent predictive reliability across both training and validation datasets, providing valuable insights for prognosis assessment and therapeutic strategies in CRC.
SN - 2167-8359
ER -